Cite
HARVARD Citation
Cadranel, J. et al. (n.d.). 3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort. European journal of cancer. pp. S646-. [Online].